The growth of GLP-1 use has also led to early acquisitions: in 2023, Weight Watchers acquired Sequence, a Series A telehealth company that prescribes GLP-1 drugs and provides support comprehensive services, for $132M
Control of glycemia with a basal-plus regimen in people with type 2 diabetes mellitus insufficiently controlled by previous treatment
LC-MS/MS was used for the analysis of semaglutide in human plasma on a UPLC BEH300 C18 column to investigate the effects of various dosing schedules on the pharmacokinetics following oral administration of the drug [68]
These medications help regulate blood sugar, control appetite, and enhance metabolism, making them highly effective for weight management
Integrated proteomic and N-glycoproteomic profiling of placental tissues of patients with preeclampsia
A few months later, he reached out to Cuban the way that many entrepreneurs do: a cold email